the aid library

LIST OPTIONS

Filter

1821

Sort by:

Direction:

Download (1326)

View PDF (3213)

Infection Control Assessment Tool: A Standardized Approach for Improving Hospital Infection Control Practices

South Africa's Dept. of Health; USAID; SIAPS (2010) C1

The ICAT is a simple and practical approach for assessing the adequacy of existing infection prevention and control practices and provides specific recommendations for improving practices and monitoring their effectiveness over time

Download (698)

View PDF (946)

Tuberculosis Infection Prevention and Control in Ghana

Meis, M.; V. Lipke, M. Girma, et al. KNCV; CDC; USAID, et al. (2010) C1

Download (7969)

View PDF (5646)

Practical Guidelines for Infection Control in Health Care Facilities
recommended

Manju Vatsa, Duangvadee Sungkhobol, Sudarshan Kumari, et al. WHO Western Pacific, Manila, and WHO South-East Asia, New Delhi (2004)

Download (728)

View PDF (995)

Liberia: Ministry of Health and Social Welfare 2013 Annual Report

Ministry of Health and Social Welfare Liberia (2014) C1

Download (366)

View PDF (885)

Special Report Mental Health and Human Rights in Cambodia

Daniel McLaughlin Leitner Center for International Law and Justice (2009) CC

Download (702)

View PDF (1150)

Liberia: Ministry of Health and Social Welfare 2012 Annual Report

Ministry of Health and Social Welfare, Liberia (2012) C1

Download (2636)

View PDF (1301)

Monitoring and Evaluation Toolkit: HIV, TB and Malaria and Health Systems Strenghtening

The Global Fund (2011)

The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy... more

Download (742)

View PDF (1406)

Guidelines for Implementing Collaborative TB and HIV Programme Activities

Stop TB Partnership. Working Group on TBHIV. Scientific Panel WHO (2003) C_WHO

The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active antiretroviral treatment (HAART)... more

Download (796)

View PDF (1028)

Pioneer Project: A holistic systems strengthening approach towards Malaria control in Mid-Western Uganda

Malaria Consortium and Comic Relief (2014) C1

Successes and lessons

Download (1047)

View PDF (1939)

Comprehensive cervical cancer prevention and control

World Health Organization (2013) C_WHO

This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life course from childhood through to adulthood. These inclu... more

Download (797)

View PDF (1198)

Human Leptospirosis: Guidance for diagnosis, surveillance and control

World Health Organization (2002)

Download (2005)

View PDF (2036)

Prevention and control of epidemic meningococcal disease in Africa

WHO (2002)

Report of a WHO technical consultation meeting Ouagadougou, Burkina Faso

Download (161)

View PDF (193)

Interregional meeting on leishmaniasis among neighbouring endemic countries in the Eastern Mediterranean, African and European regions

World Health Organization WHO WHO (2019) C_WHO

An interregional meeting on leishmaniasis among neighbouring endemic countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w... more

Download (110)

View PDF (127)

WHO Timor-Leste Country Cooperation Strategy: 2021-2025

World Health Organisation (WHO) (2023) C_WHO

In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta... more

Download (93)

View PDF (105)

WHO South Sudan Annual Report 2022

World Health Organisation (WHO) (2023) C_WHO

A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase access to quality healthcare services. To furth... more

Download (239)

View PDF (322)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (33)

View PDF (23)

Operational guidance on the use of yellow fever assays in the context of surveillance

World Health Organization WHO (2023) C_WHO

This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm... more

Download (128)

View PDF (111)

WHO's Health Emergency Appeal 2024

World Health Organization WHO (2024) C_WHO

In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.

Download (111)

View PDF (116)

Psychological interventions implementation manual: Integrating evidence-based psychological interventions into existing services

World Health Organization WHO (2024) C_WHO

Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progression towards universal health coverage. This manual provides managers and others responsible for plan... more

Download (21)

View PDF (10)

WHO Country Office in Ukraine annual report 2023

World Health Organisation (WHO) (2024) C_WHO

This report provides an overview of the operations and activities of the WHO Country Office in Ukraine in 2023. Despite the acute health impacts of the war in Ukraine, the Country Office continued its work according to its core mandate. WHO supported the Government of Ukraine in managing the health ... more

Practical Guidelines for Infection Control in Health Care Facilities recommended

Practical Guidelines for Infection Control in Health Care Facilities
recommended